Human Vaccines Market Trend, Share, Growth, Size and Forecast 2032

• Chapter 1 Preface
  • 1.1 Report Description
  • 1.1 Report Scope
• Chapter 2 Research Methodology
  • 2.1 Research Methodology
  • 2.2 Secondary Research
  • 2.3 Primary Research
  • 2.4 Models
    • 2.4.1 Company Share Analysis Model
    • 2.4.2 Revenue Based Modeling
  • 2.5 Research Limitations
• Chapter 3 Executive Summary
  • 3.1 Global Human Vaccines Market, 2016 – 2026 (USD Billion)
  • 3.2 Global Human Vaccines Market: Snapshot
• Chapter 4 Human Vaccines Market – Industry Analysis
  • 4.1 Introduction
  • 4.2 Market Drivers
    • 4.2.1 Driving Factor 1 Analysis
    • 4.2.2 Driving Factor 2 Analysis:
  • 4.3 Market Restraints
    • 4.3.1 Restraining Factor Analysis
  • 4.4 Market Opportunities
    • 4.4.1 Market Opportunity & Use-case Analysis
    • 4.4.2 Use – Cases for Human Vaccines
  • 4.5 Porter’s Five Forces Analysis
  • 4.6 COVID 19 Impact Analysis
    • 4.6.1.1 Impact on Product Development and Technology Adoption
    • 4.6.1.2 Gap Analysis
• Chapter 5 Investment Proposition Analysis
  • 5.1 Global Human Vaccines Market Attractiveness, By Products
  • 5.2 Global Human Vaccines Market Attractiveness, By Age Group
  • 5.3 Global Human Vaccines Market Attractiveness, By Distribution Channel
  • 5.4 Global Human Vaccines Market Attractiveness, By Type
  • 5.5 Global Human Vaccines Market Attractiveness, By Region
• Chapter 6 Competitive Landscape
  • 6.1 Company Market Share Analysis - 2019
    • 6.1.1 Global Human Vaccines Market: Company Market Share, 2019
  • 6.2 Strategic Developments
  • 7.1 Global Human Vaccines Market Overview: by Products
    • 7.1.1 Global Human Vaccines Market Revenue Share, by Products, 2019 & 2026
  • 7.2 Global Human Vaccines Market Analysis/Overview – By Products
    • 7.2.1 Influenza – Overview/Analysis
    • 7.2.2 Pneumococcal – Overview/Analysis
    • 7.2.3 HPV – Overview/Analysis
    • 7.2.4 Hepatitis – Overview/Analysis
    • 7.2.5 Rotavirus – Overview/Analysis
    • 7.2.6 Meningococcal – Overview/Analysis
    • 7.2.7 Mumps – Overview/Analysis
    • 7.2.8 Measles – Overview/Analysis
    • 7.2.9 Typhoid – Overview/Analysis
    • 7.2.10 Others – Overview/Analysis
  • 7.3 Influenza
    • 7.3.1 Global Human Vaccines Market for Influenza, Revenue (USD Billion) 2016 - 2026
  • 7.4 Pneumococcal
    • 7.4.1 Global Human Vaccines Market for Pneumococcal, Revenue (USD Billion) 2016 - 2026
  • 7.5 HPV
    • 7.5.1 Global Human Vaccines Market for HPV, Revenue (USD Billion) 2016 - 2026
  • 7.6 Hepatitis
    • 7.6.1 Global Human Vaccines Market for Hepatitis, Revenue (USD Billion) 2016 - 2026
  • 7.7 Rotavirus
    • 7.7.1 Global Human Vaccines Market for Rotavirus, Revenue (USD Billion) 2016 - 2026
  • 7.8 Meningococcal
    • 7.8.1 Global Human Vaccines Market for Meningococcal, Revenue (USD Billion) 2016 - 2026
  • 7.9 Mumps
    • 7.9.1 Global Human Vaccines Market for Mumps, Revenue (USD Billion) 2016 - 2026
  • 7.10 Measles
    • 7.10.1 Global Human Vaccines Market for Measles, Revenue (USD Billion) 2016 - 2026
  • 7.11 Typhoid
    • 7.11.1 Global Human Vaccines Market for Typhoid, Revenue (USD Billion) 2016 - 2026
  • 7.12 Others
    • 7.12.1 Global Human Vaccines Market for Others, Revenue (USD Billion) 2016 - 2026
  • 8.1 Global Human Vaccines Market Overview: by Age Group
    • 8.1.1 Global Human Vaccines Market Revenue Share, by Age Group, 2019 & 2026
  • 8.2 Global Human Vaccines Market Analysis/Overview – By Age Group
    • 8.2.1 Adulescent – Overview/Analysis
    • 8.2.2 Pediatrics – Overview/Analysis
    • 8.2.3 Geriatrics – Overview/Analysis
    • 8.2.4 Adult – Overview/Analysis
  • 8.3 Adulescent
    • 8.3.1 Global Human Vaccines Market for Adulescent, Revenue (USD Billion) 2016 - 2026
  • 8.4 Pediatrics
    • 8.4.1 Global Human Vaccines Market for Pediatrics, Revenue (USD Billion) 2016 - 2026
  • 8.5 Geriatrics
    • 8.5.1 Global Human Vaccines Market for Geriatrics, Revenue (USD Billion) 2016 - 2026
  • 8.6 Adult
    • 8.6.1 Global Human Vaccines Market for Adult, Revenue (USD Billion) 2016 - 2026
  • 9.1 Global Human Vaccines Market Overview: by Distribution Channel
    • 9.1.1 Global Human Vaccines Market Revenue Share, by Distribution Channel, 2019 & 2026
  • 9.2 Global Human Vaccines Market Analysis/Overview – By Distribution Channel
    • 9.2.1 Drugstores – Overview/Analysis
    • 9.2.2 Hospital – Overview/Analysis
    • 9.2.3 Pharmacies – Overview/Analysis
    • 9.2.4 Others – Overview/Analysis
  • 9.3 Drugstores
    • 9.3.1 Global Human Vaccines Market for Drugstores, Revenue (USD Billion) 2016 - 2026
  • 9.4 Hospital
    • 9.4.1 Global Human Vaccines Market for Hospital, Revenue (USD Billion) 2016 - 2026
  • 9.5 Pharmacies
    • 9.5.1 Global Human Vaccines Market for Pharmacies, Revenue (USD Billion) 2016 - 2026
  • 9.6 Others
    • 9.6.1 Global Human Vaccines Market for Others, Revenue (USD Billion) 2016 - 2026
  • 10.1 Global Human Vaccines Market Overview: by Type
    • 10.1.1 Global Human Vaccines Market Revenue Share, by Type, 2019 & 2026
  • 10.2 Global Human Vaccines Market Analysis/Overview – By Type
    • 10.2.1 Attenuated – Overview/Analysis
    • 10.2.2 Recombinant – Overview/Analysis
    • 10.2.3 Conjugate – Overview/Analysis
    • 10.2.4 Combination – Overview/Analysis
    • 10.2.5 Inactivated – Overview/Analysis
    • 10.2.6 Others – Overview/Analysis
    • 10.2.7 Others – Overview/Analysis
  • 10.3 Attenuated
    • 10.3.1 Global Human Vaccines Market for Attenuated, Revenue (USD Billion) 2016 - 2026
  • 10.4 Recombinant
    • 10.4.1 Global Human Vaccines Market for Recombinant, Revenue (USD Billion) 2016 - 2026
  • 10.5 Conjugate
    • 10.5.1 Global Human Vaccines Market for Conjugate, Revenue (USD Billion) 2016 - 2026
  • 10.6 Combination
    • 10.6.1 Global Human Vaccines Market for Combination, Revenue (USD Billion) 2016 - 2026
  • 10.7 Inactivated
    • 10.7.1 Global Human Vaccines Market for Inactivated, Revenue (USD Billion) 2016 - 2026
  • 10.8 Others
    • 10.8.1 Global Human Vaccines Market for Others, Revenue (USD Billion) 2016 - 2026
  • 10.9 Others
    • 10.9.1 Global Human Vaccines Market for Others, Revenue (USD Billion) 2016 - 2026
• Chapter 11 Human Vaccines Market – Regional Analysis
  • 11.1 Global Human Vaccines Market: Regional Overview
    • 11.1.1 Global Human Vaccines Market Revenue Share, by Region, 2019 & 2026
    • 11.1.2 Global Human Vaccines Market Revenue, by Region, 2016 – 2026 (USD Billion)
  • 11.2 North America
    • 11.2.1 North America Human Vaccines Market Revenue, 2016 - 2026 (USD Billion)
    • 11.2.2 North America Human Vaccines Market Revenue, by Country, 2016 – 2026 (USD Billion)
    • 11.2.3 North America Human Vaccines Market Revenue, by Products, 2016 – 2026
    • 11.2.4 North America Human Vaccines Market Revenue, by Age Group, 2016 – 2026
    • 11.2.5 North America Human Vaccines Market Revenue, by Distribution Channel, 2016 – 2026
    • 11.2.6 North America Human Vaccines Market Revenue, by Type, 2016 – 2026
    • 11.2.7 U.S.
    • 11.2.8 Canada
  • 11.3 Europe
    • 11.3.1 Europe Human Vaccines Market Revenue, 2016 - 2026 (USD Billion)
    • 11.3.2 Europe Human Vaccines Market Revenue, by Country, 2016 – 2026 (USD Billion)
    • 11.3.3 Europe Human Vaccines Market Revenue, by Products, 2016 – 2026
    • 11.3.4 Europe Human Vaccines Market Revenue, by Age Group, 2016 – 2026
    • 11.3.5 Europe Human Vaccines Market Revenue, by Distribution Channel, 2016 – 2026
    • 11.3.6 Europe Human Vaccines Market Revenue, by Type, 2016 – 2026
    • 11.3.7 Germany
    • 11.3.8 France
    • 11.3.9 U.K.
    • 11.3.10 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Human Vaccines Market Revenue, 2016 - 2026 (USD Billion)
    • 11.4.2 Asia Pacific Human Vaccines Market Revenue, by Country, 2016 – 2026 (USD Billion)
    • 11.4.3 Asia Pacific Human Vaccines Market Revenue, by Products, 2016 – 2026
    • 11.4.4 Asia Pacific Human Vaccines Market Revenue, by Age Group, 2016 – 2026
    • 11.4.5 Asia Pacific Human Vaccines Market Revenue, by Distribution Channel, 2016 – 2026
    • 11.4.6 Asia Pacific Human Vaccines Market Revenue, by Type, 2016 – 2026
    • 11.4.7 China
    • 11.4.8 India
    • 11.4.9 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Latin America Human Vaccines Market Revenue, 2016 - 2026 (USD Billion)
    • 11.5.2 Latin America Human Vaccines Market Revenue, by Country, 2016 – 2026 (USD Billion)
    • 11.5.3 Latin America Human Vaccines Market Revenue, by Products, 2016 – 2026
    • 11.5.4 Latin America Human Vaccines Market Revenue, by Age Group, 2016 – 2026
    • 11.5.5 Latin America Human Vaccines Market Revenue, by Distribution Channel, 2016 – 2026
    • 11.5.6 Latin America Human Vaccines Market Revenue, by Type, 2016 – 2026
    • 11.5.7 Brazil
    • 11.5.8 Rest of Latin America
  • 11.6 The Middle-East and Africa
    • 11.6.1 The Middle-East and Africa Human Vaccines Market Revenue, 2016 - 2026 (USD Billion)
    • 11.6.2 The Middle-East and Africa Human Vaccines Market Revenue, by Country, 2016 – 2026 (USD Billion)
    • 11.6.3 The Middle-East and Africa Human Vaccines Market Revenue, by Products, 2016 – 2026
    • 11.6.4 The Middle-East and Africa Human Vaccines Market Revenue, by Age Group, 2016 – 2026
    • 11.6.5 The Middle-East and Africa Human Vaccines Market Revenue, by Distribution Channel, 2016 – 2026
    • 11.6.6 The Middle-East and Africa Human Vaccines Market Revenue, by Type, 2016 – 2026
    • 11.6.7 GCC Countries
    • 11.6.8 Rest of Middle-East Africa
• Chapter 12 Company Profiles
  • 12.1 GeneOne Life Science Inc.
    • 12.1.1 Company Overview
    • 12.1.2 Financial Overview
    • 12.1.3 Product Portfolio
    • 12.1.4 Business Strategy
    • 12.1.5 Recent Developments
  • 12.2 Inovio Pharmaceuticals, Inc.
  • 12.3 Immunomic Therapeutics
  • 12.4 MedImmune
  • 12.5 Pharos Biulogicals
  • 12.6 Astellas Pharma, Inc.
  • 12.7 Hoffmann-La Roche AG
  • 12.8 Sanofi S.A
    • 12.9 F. Boehringer Ingelheim GmbH

Table Of Figures

List of Figures 

FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Human Vaccines Market Revenue, 2016 - 2026 (USD Billion)
FIG. 5 Porter’s Five Forces Analysis for Global Human Vaccines Market
FIG. 6 Global Human Vaccines Market Attractiveness, By Products
FIG. 7 Global Human Vaccines Market Attractiveness, By Age Group
FIG. 8 Global Human Vaccines Market Attractiveness, By Distribution Channel
FIG. 9 Global Human Vaccines Market Attractiveness, By Type
FIG. 10 Global Human Vaccines Market Attractiveness, By End-User
FIG. 11 Company Share Analysis, 2019
FIG. 12 Global Human Vaccines Market Revenue Share, by Products, 2019 & 2026
FIG. 13 Global Human Vaccines Market for Influenza, Revenue (USD Billion) 2016 - 2026
FIG. 14 Global Human Vaccines Market for Pneumococcal, Revenue (USD Billion) 2016 - 2026
FIG. 15 Global Human Vaccines Market for HPV, Revenue (USD Billion) 2016 - 2026
FIG. 16 Global Human Vaccines Market for Hepatitis, Revenue (USD Billion) 2016 - 2026
FIG. 17 Global Human Vaccines Market for Rotavirus, Revenue (USD Billion) 2016 - 2026
FIG. 18 Global Human Vaccines Market for Meningococcal, Revenue (USD Billion) 2016 - 2026
FIG. 19 Global Human Vaccines Market for Mumps, Revenue (USD Billion) 2016 - 2026
FIG. 20 Global Human Vaccines Market for Measles, Revenue (USD Billion) 2016 - 2026
FIG. 21 Global Human Vaccines Market for Typhoid, Revenue (USD Billion) 2016 - 2026
FIG. 22 Global Human Vaccines Market for Others, Revenue (USD Billion) 2016 - 2026
FIG. 23 Global Human Vaccines Market Revenue Share, by Age Group, 2019 & 2026
FIG. 24 Global Human Vaccines Market for Adolescent, Revenue (USD Billion) 2016 - 2026
FIG. 25 Global Human Vaccines Market for Pediatrics, Revenue (USD Billion) 2016 - 2026
FIG. 26 Global Human Vaccines Market for Geriatrics, Revenue (USD Billion) 2016 - 2026
FIG. 27 Global Human Vaccines Market for Adult, Revenue (USD Billion) 2016 - 2026
FIG. 28 Global Human Vaccines Market Revenue Share, by Distribution Channel, 2019 & 2026
FIG. 29 Global Human Vaccines Market for Drugstores, Revenue (USD Billion) 2016 - 2026
FIG. 30 Global Human Vaccines Market for Hospital, Revenue (USD Billion) 2016 - 2026
FIG. 31 Global Human Vaccines Market for Pharmacies, Revenue (USD Billion) 2016 - 2026
FIG. 32 Global Human Vaccines Market for Others, Revenue (USD Billion) 2016 - 2026
FIG. 33 Global Human Vaccines Market Revenue Share, by Type, 2019 & 2026
FIG. 34 Global Human Vaccines Market for Attenuated, Revenue (USD Billion) 2016 - 2026
FIG. 35 Global Human Vaccines Market for Recombinant, Revenue (USD Billion) 2016 - 2026
FIG. 36 Global Human Vaccines Market for Conjugate, Revenue (USD Billion) 2016 - 2026
FIG. 37 Global Human Vaccines Market for Combination, Revenue (USD Billion) 2016 - 2026
FIG. 38 Global Human Vaccines Market for Inactivated, Revenue (USD Billion) 2016 - 2026
FIG. 39 Global Human Vaccines Market for Others, Revenue (USD Billion) 2016 - 2026
FIG. 40 Global Human Vaccines Market for Others, Revenue (USD Billion) 2016 - 2026
FIG. 41 Global Human Vaccines Market Revenue Share, by Region, 2019 & 2026
FIG. 42 North America Human Vaccines Market Revenue, 2016 - 2026 (USD Billion)
FIG. 43 Europe Human Vaccines Market Revenue, 2016 - 2026 (USD Billion)
FIG. 44 Asia Pacific Human Vaccines Market Revenue, 2016 - 2026 (USD Billion)
FIG. 45 Latin America Human Vaccines Market Revenue, 2016 - 2026 (USD Billion)
FIG. 46 The Middle-East and Africa Human Vaccines Market Revenue, 2016 - 2026 (USD Billion)
FIG. 47 GeneOne Life Science Inc. Business Segment Revenue Share, 2018 (%)
FIG. 48 GeneOne Life Science Inc. Geographical Segment Revenue Share, 2018 (%)

Table Of Tables

List of Tables

TABLE 1 Global Human Vaccines Market: Snapshot
TABLE 2 Drivers of the Human Vaccines Market: Impact Analysis
TABLE 3 Restraints for the Human Vaccines Market: Impact Analysis
TABLE 4 Global Human Vaccines Market Revenue, by Region, 2016 – 2026 (USD Billion)
TABLE 5 North America Human Vaccines Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 6 North America Human Vaccines Market Revenue, by Products, 2016 – 2026 (USD Billion)
TABLE 7 North America Human Vaccines Market Revenue, by Age Group, 2016 – 2026 (USD Billion)
TABLE 8 North America Human Vaccines Market Revenue, by Distribution Channel, 2016 – 2026 (USD Billion)
TABLE 9 North America Human Vaccines Market Revenue, by Type, 2016 – 2026 (USD Billion)
TABLE 10 Europe Human Vaccines Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 11 Europe Human Vaccines Market Revenue, by Products, 2016 – 2026 (USD Billion)
TABLE 12 Europe Human Vaccines Market Revenue, by Age Group, 2016 – 2026 (USD Billion)
TABLE 13 Europe Human Vaccines Market Revenue, by Distribution Channel, 2016 – 2026 (USD Billion)
TABLE 14 Europe Human Vaccines Market Revenue, by Type, 2016 – 2026 (USD Billion)
TABLE 15 Asia Pacific Human Vaccines Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 16 Asia Pacific Human Vaccines Market Revenue, by Products, 2016 – 2026 (USD Billion)
TABLE 17 Asia Pacific Human Vaccines Market Revenue, by Age Group, 2016 – 2026 (USD Billion)
TABLE 18 Asia Pacific Human Vaccines Market Revenue, by Distribution Channel, 2016 – 2026 (USD Billion)
TABLE 19 Asia Pacific Human Vaccines Market Revenue, by Type, 2016 – 2026 (USD Billion)
TABLE 20 Latin America Human Vaccines Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 21 Latin America Human Vaccines Market Revenue, by Products, 2016 – 2026 (USD Billion)
TABLE 22 Latin America Human Vaccines Market Revenue, by Age Group, 2016 – 2026 (USD Billion)
TABLE 23 Latin America Human Vaccines Market Revenue, by Distribution Channel, 2016 – 2026 (USD Billion)
TABLE 24 Latin America Human Vaccines Market Revenue, by Type, 2016 – 2026 (USD Billion)
TABLE 25 The Middle-East and Africa Human Vaccines Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 26 The Middle-East and Africa Human Vaccines Market Revenue, by Products, 2016 – 2026 (USD Billion)
TABLE 27 The Middle-East and Africa Human Vaccines Market Revenue, by Age Group, 2016 – 2026 (USD Billion)
TABLE 28 The Middle-East and Africa Human Vaccines Market Revenue, by Distribution Channel, 2016 – 2026 (USD Billion)
TABLE 29 The Middle-East and Africa Human Vaccines Market Revenue, by Type, 2016 – 2026 (USD Billion)